ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE FAMILY IN RAT PITUITARY GH3 CELLS

大鼠垂体 GH3 细胞中有丝分裂原激活蛋白激酶家族的激活

基本信息

  • 批准号:
    10671541
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

In GH3 cells, we examined the Mitogen-activated protein kinase (MAP kinase) activation induced by thyrotropin-releasing hormone (TRH) and the role of MAP kinase activation in secretory processes and prolactin (PRL) synthesis. Immunoblotting analysis indicated the presence of only 42 kDa MAP kinase in GH3 cells. TRH induced rapid activation of MAP kinase, which reached a maximal peak of 300 A ィイD4oィエD4i at 5-10 min. TRH-induced MAP kinase activation was inhibited completely by PD098059, and 80 % by calphostin C, respectively. Genistein and removal of extracellular Ca2+ also partially inhibited TRH-induced MAP kinase activation. These results suggest that TRH-induced MAP kinase activation is largely PKC-dependent and partially dependent on the Ca2+-dependent tyrosine kinase. CTPcAMP increased MAP kinase activity significantly, and CPTcAMP effects were inhibited by PD098059. TRH-induced prolactin secretion was not affected by exposure to PD098059, but completely blocked by either wortmannin or KN93. Synthesis of PRL induced by TFH was completely blocked by addition PC098059. These results suggest that TRH-induced MAP kinase activation is correlated with synthesis of PRL but not with PRL secretion. TRH increased the PRL synthesis, while growth hormone synthesis largely decreased by TRH. Treatment of GH3 cells with bromocriptine for 48th increased the p38 MAP kinase activity, and simultaneously increased the number of apoptotic cells. SB202190 and SB203580 completely inhibited the bromocriptine-induced p38 MAP kinase activation, and reduced the number of apoptotic cells. We have shown that TRH induces P44/42 MAP kinase activation in GH3 cells. TRH may be involved in PRL secretion through activation of myosin light chain kinase and CaM kinase II, and in PRL synthesis and differentiation of the cells through activation of P44/42 MAP kinase. The p38 MAP kinase activation induced by bromocriptine was strongly involved in induction of apoptosis.
在GH 3细胞中,我们研究了促甲状腺激素释放激素(TRH)诱导的有丝分裂原活化蛋白激酶(MAP激酶)激活以及MAP激酶激活在分泌过程和催乳素(PRL)合成中的作用。免疫印迹分析表明GH 3细胞中仅存在42 kDa的MAP激酶。TRH诱导MAP激酶的快速激活,其在5-10 min时达到300 A的最大峰值,PD 098059和calphostin C分别完全抑制TRH诱导的MAP激酶激活,抑制率分别为80%。Genistein和细胞外Ca ~(2+)的去除也部分抑制TRH诱导的MAP激酶激活。这些结果表明,TRH诱导的MAP激酶激活在很大程度上是PKC依赖性的,部分依赖于Ca 2+依赖性酪氨酸激酶。CTPcAMP显著增加MAP激酶活性,PD 098059可抑制CPTcAMP的作用。TRH诱导的催乳素分泌不受暴露于PD 098059的影响,但完全阻断渥曼青霉素或KN 93。加入PC 098059可完全阻断TFH诱导的PRL合成。这些结果表明,TRH诱导的MAP激酶激活与PRL的合成,但不与PRL分泌。TRH增加PRL的合成,而生长激素的合成大大减少TRH。溴隐亭处理GH 3细胞48 h后,p38 MAP激酶活性增加,凋亡细胞数增加。SB 202190和SB 203580完全抑制溴隐亭诱导的p38 MAP激酶激活,并减少凋亡细胞的数量。我们已经证明,TRH诱导P44/42 MAP激酶在GH 3细胞中的激活。TRH可能通过激活肌球蛋白轻链激酶和CaM激酶II参与PRL分泌,通过激活P44/42 MAP激酶参与PRL合成和细胞分化。溴隐亭诱导的p38 MAP激酶激活强烈参与诱导细胞凋亡。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Haruhiko Kanasaki: "Involvement of p38 Mitogen-activated Protein Kinase Activation in Bromocriptine-Induced Apoptosis in Rat Pituitary GH3 Cells"Biology of Reproduction. (In press). (2000)
Haruhiko Kanasaki:“p38 丝裂原激活蛋白激酶激活参与溴隐亭诱导的大鼠垂体 GH3 细胞凋亡”生殖生物学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Haruhiko Kanasaki et al.: "Involvemet of p38 Mitogen-Activated Protein Kinase Activation in Bromocriptine-Induced Apoptosis in Rat Pituitary GH3 cells"BIOLOGY OF REPRODUCTION. (in press). (2000)
Haruhiko Kanasaki 等人:“溴隐亭诱导大鼠垂体 GH3 细胞凋亡中 p38 丝裂原激活蛋白激酶激活的参与”生殖生物学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIYAZAKI Kohji其他文献

MIYAZAKI Kohji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIYAZAKI Kohji', 18)}}的其他基金

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
通过全基因组分析鉴定子宫浆液性癌的分子途径畸变。
  • 批准号:
    23592450
  • 财政年份:
    2011
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of hypothalamic neuropeptides in the regulation of gonadotropins
下丘脑神经肽在促性腺激素调节中的作用
  • 批准号:
    20591916
  • 财政年份:
    2008
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Nobel therapeutic strategy based on deficient expression of DNA repair gene in gastrointestinal cancers.
基于胃肠癌DNA修复基因表达缺陷的诺贝尔治疗策略。
  • 批准号:
    15390400
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of DNA repair gene MGMT, hMLHI and hMSH2 in oncogenesis and progression of human gastrointestinal, hepatobiliary carcinoma
DNA修复基因MGMT、hMLHI和hMSH2在人胃肠道、肝胆癌发生和进展中的作用
  • 批准号:
    12470263
  • 财政年份:
    2000
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Factors affecting morphogenesis of normal gallbladder epithelial cells and those regulationg differentiation in gallbladder cancer cells.
影响正常胆囊上皮细胞形态发生的因素和调节胆囊癌细胞分化的因素。
  • 批准号:
    09671322
  • 财政年份:
    1997
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the Carcinogenesis and the Morphogenic Factors of Gallbladder Cancer.
胆囊癌发生及形态发生因素的研究。
  • 批准号:
    07671407
  • 财政年份:
    1995
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the mechanism of the chemical carcinogenesis of cirrhotic liver
肝硬化肝化学致癌机制研究
  • 批准号:
    03670634
  • 财政年份:
    1991
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Study on the mechanism of the carcinogenesis of the biliary tract.
胆道癌变机制的研究。
  • 批准号:
    01570760
  • 财政年份:
    1989
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Study on the development of the short-term screening model for chemical carcinogenic agents and its application in relation to biliary tract cancer.
化学致癌剂短期筛查模型的建立及其在胆道癌中的应用研究。
  • 批准号:
    62570610
  • 财政年份:
    1987
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Elucidation of regulatory mechanisms of the growth hormone cytokinin and nitrogen dynamics in plant adaptation to nitrate fluctuation stress
阐明植物适应硝酸盐波动胁迫中生长激素细胞分裂素和氮动态的调节机制
  • 批准号:
    24K18138
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Growth hormone regulating chondrocyte metabolism for osteoarthritis development
生长激素调节软骨细胞代谢促进骨关节炎的发展
  • 批准号:
    10730575
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Developing helical peptide antagonists of the growth hormone receptor
开发生长激素受体的螺旋肽拮抗剂
  • 批准号:
    10648820
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Central Mediation of Growth Hormone Effects in Humans
人类生长激素效应的中枢调节
  • 批准号:
    10659801
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE
人类生长激素接受者的克雅氏病监测
  • 批准号:
    10973401
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Metabolomic Investigation of the Impact of Growth Hormone on Nonalcoholic Fatty Liver Disease: Identification of Novel Biomarkers and Therapeutic Targets
生长激素对非酒精性脂肪肝影响的代谢组学研究:新型生物标志物和治疗靶点的鉴定
  • 批准号:
    10451082
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Metabolomic Investigation of the Impact of Growth Hormone on Nonalcoholic Fatty Liver Disease: Identification of Novel Biomarkers and Therapeutic Targets
生长激素对非酒精性脂肪肝影响的代谢组学研究:新型生物标志物和治疗靶点的鉴定
  • 批准号:
    10608193
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE
人类生长激素接受者的克雅氏病监测
  • 批准号:
    10657314
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Bidirectional Relationship Between Growth Hormone and Sleep Following Juvenile TBI
青少年创伤性脑损伤后生长激素与睡眠之间的双向关系
  • 批准号:
    10403208
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
Bidirectional Relationship Between Growth Hormone and Sleep Following Juvenile TBI
青少年创伤性脑损伤后生长激素与睡眠之间的双向关系
  • 批准号:
    10358049
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了